Steroids & Testosterone: The Science Behind Anabolic Therapies with Nelson Vergel
About this video
Dr. Lyon interviews Nelson Virgil, an HIV survivor diagnosed in the 1980s who pioneered anabolic steroid use to reverse wasting syndrome when no treatments existed. Virgil shares how he became an activist educating physicians on FDA-approved androgens like nandrolone and oxandrolone, establishing programs that helped thousands survive by preserving lean body mass. They discuss the medical applications, safety profiles, and persistent stigmas around anabolic agents, arguing these compounds could address modern challenges like sarcopenia and GLP-1-induced muscle loss.
Key takeaways
- Virgil claims bodybuilders using anabolic steroids in the 1980s showed him how to reverse HIV-related wasting, gaining 35 pounds and buying time until better HIV treatments arrived in the mid-1990s
- According to Virgil, FDA-approved androgens like nandrolone and oxandrolone can safely preserve lean body mass at physiologic doses (he suggests 50-100mg weekly for men, 25mg for women with nandrolone) when combined with testosterone
- Virgil argues the Anabolic Steroid Control Act created stigma that blocks research and clinical use despite safety data, and suggests these agents could prevent muscle loss in GLP-1 users and aging populations
Episode details: published March 18, 2025 · 21K views · 1:35:42 long. Summary written by Self Growth Videos from the episode itself. The health and muscle concepts described are Dr. Gabrielle Lyon’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices.
← Previous: The Truth About Calories & Weight Loss | Dr. James Hill · Next: Keep Your Joints & Bones Strong for Life | The Science of Arthritis | Jocelyn Wittstein →
All Dr. Gabrielle Lyon videos · Dr. Gabrielle Lyon profile · Dr. Gabrielle Lyon on YouTube
You Might Also Enjoy

The Muscle Myth GLP-1 Users Have Been Lied to About | GLS #227
Explore →
5 Hidden Causes of Bone Loss (#4 Is a Shock) - Dr. Douglas Lucas | GLS #222
Explore →
GLP-1 Side Effects, Risks, And Who Should Be Using It | Dr. Christle Guevarra | GLS #202
Explore →
The Coming Epidemic: Trading Obesity for Sarcopenia and Why Protein Is Our Only Defense
Explore →
GLP-1 Drugs Work… But Here’s the Catch
Explore →